Publicaciones

Todas nuestras publicaciones

*Se listan los artículos que se encuentran en la base de datos del PubMed

Publicaciones de “Isabel Lastres Becker”

Corrigendum to "Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases" [Redox Biol. 79 (2025) 103464].

Rojo, AI , Buttari, B, Cadenas, S, Carlos, AR, Cuadrado, A , Falcão, AS, López, MG, Georgiev, MI, Grochot-Przeczek, A, Gumeni, S, Jiménez-Villegas, J , Horbanczuk, JO, Konu, O, Lastres-Becker, I , Levonen, AL, Maksimova, V, Michaeloudes, C, Mihaylova, LV, Mickael, ME, Milisav, I, Miova, B, Rada, P , Santos, M, Seabra, MC, Strac, DS, Tenreiro, S, Trougakos, IP, Dinkova-Kostova, AT.

Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.

Rojo, AI , Buttari, B, Cadenas, S, Carlos, AR, Cuadrado, A , Falcão, AS, López, MG, Georgiev, MI, Grochot-Przeczek, A, Gumeni, S, Jimenez-Villegas, J, Horbanczuk, JO, Konu, O, Lastres-Becker, I , Levonen, AL, Maksimova, V, Michaeloudes, C, Mihaylova, LV, Mickael, ME, Milisav, I, Miova, B, Rada, P , Santos, M, Seabra, MC, Strac, DS, Tenreiro, S, Trougakos, IP, Dinkova-Kostova, AT.

Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

Burgaz, S, Navarro, E, Rodríguez-Carreiro, S, Navarrete, C, Garrido-Rodríguez, M, Lastres-Becker, I , Chocarro, J, Lanciego, JL, Muñoz, E, Fernández-Ruiz, J.

Biomarkers of NRF2 signalling: Current status and future challenges.

Morgenstern, C, Lastres-Becker, I , Demirdöğen, BC, Costa, VM, Daiber, A, Foresti, R, Motterlini, R, Kalyoncu, S, Arioz, BI, Genc, S, Jakubowska, M, Trougakos, IP, Piechota-Polanczyk, A, Mickael, M, Santos, M, Kensler, TW, Cuadrado, A , Copple, IM.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).

Klionsky, DJ, [ .., ], Bartolome, A , [ .., ], Cuadrado, A , [ .., ], Escalante, R , [ .., ], García-Sanz, P , [ .., ], Lastres-Becker, I , [ .., ], León, Y , [ .., ], Martin-Sanz, P , [ .., ], Pajares, M , [ .., ], Rojo, AI , [ .., ], Valverde, AM , [ .., ], Varela-Nieto, I , [ .., ], Villalobo, A , [ .., ], Vincent, O , [ .., ], Tong, CK.

Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K/mTOR and is induced by starvation.

Lastres-Becker, I , Nonis, D, Eich, F, Klinkenberg, M, Gorospe, M, Kötter, P, Klein, FA, Kedersha, N, Auburger, G.

Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate.

Fittschen, M, Lastres-Becker, I , Halbach, MV, Damrath, E, Gispert, S, Azizov, M, Walter, M, Müller, S, Auburger, G.

Nrf2 protects the lung against inflammation induced by titanium dioxide nanoparticles: A positive regulator role of Nrf2 on cytokine release.

Delgado-Buenrostro, NL, Medina-Reyes, EI, Lastres-Becker, I , Freyre-Fonseca, V, Ji, Z, Hernández-Pando, R, Marquina, B, Pedraza-Chaverri, J, Espada, S , Cuadrado, A , Chirino, YI.

A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.

Kurz, A, Double, KL, Lastres-Becker, I , Tozzi, A, Tantucci, M, Bockhart, V, Bonin, M, García-Arencibia, M, Nuber, S, Schlaudraff, F, Liss, B, Fernández-Ruiz, J, Gerlach, M, Wüllner, U, Lüddens, H, Calabresi, P, Auburger, G, Gispert, S.

Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice.

Lastres-Becker, I , Brodesser, S, Lütjohann, D, Azizov, M, Buchmann, J, Hintermann, E, Sandhoff, K, Schürmann, A, Nowock, J, Auburger, G.

An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments.

Lastres-Becker, I , Fernández-Ruiz, J.

Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.

Lastres-Becker, I , Bizat, N, Boyer, F, Hantraye, P, Fernández-Ruiz, J, Brouillet, E.

The endocannabinoid system and Huntington's disease.

Lastres-Becker, I , De Miguel, R, Fernández-Ruiz, JJ.

Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.

Lastres-Becker, I , de Miguel, R, De Petrocellis, L, Makriyannis, A, Di Marzo, V, Fernández-Ruiz, J.

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

Romero, J, Lastres-Becker, I , de Miguel, R, Berrendero, F, Ramos, JA, Fernández-Ruiz, J.

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

Lastres-Becker, I , Hansen, HH, Berrendero, F, De Miguel, R, Pérez-Rosado, A, Manzanares, J, Ramos, JA, Fernández-Ruiz, J.

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease.

Lastres-Becker, I , Berrendero, F, Lucas, JJ, Martín-Aparicio, E, Yamamoto, A, Ramos, JA, Fernández-Ruiz, JJ.

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

López-Rodríguez, ML, Viso, A, Ortega-Gutiérrez, S, Lastres-Becker, I , González, S, Fernández-Ruiz, J, Ramos, JA.

Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets.

Lastres-Becker, I , Cebeira, M, de Ceballos, ML, Zeng, BY, Jenner, P, Ramos, JA, Fernández-Ruiz, JJ.

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.

Hansen, HH, Schmid, PC, Bittigau, P, Lastres-Becker, I , Berrendero, F, Manzanares, J, Ikonomidou, C, Schmid, HH, Fernández-Ruiz, JJ, Hansen, HS.

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease.

Lastres-Becker, I , Fezza, F, Cebeira, M, Bisogno, T, Ramos, JA, Milone, A, Fernández-Ruiz, J, Di Marzo, V.

Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.

Di Marzo, V, Lastres-Becker, I , Bisogno, T, De Petrocellis, L, Milone, A, Davis, JB, Fernandez-Ruiz, JJ.

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

González, S, Romero, J, de Miguel, R, Lastres-Becker, I , Villanua, MA, Makriyannis, A, Ramos, JA, Fernández-Ruiz, JJ.

2'(3')-O-[N- [2- [3- [5-fluoresceinyl] thioureido] ethyl] carbamoyl] adenosine 5'-triphosphate and its Cr(H2O)4 and Co(NH3)4 complex derivatives are new fluorescent tools for labelling ATP binding sites of Na+/K+-ATPase.

Linnertz, H, Lastres Becker, I , Krumscheid, R, Amler, E, Thoenges, D, Schoner, W.

C/ Arturo Duperier 4 | 28029 Madrid (España) | Teléfono +(34) 91 585 4400 | Código DIR3: E02764003